BRIEF-U.S.FDA approves J&J's Olysio to treat chronic Hep C infection
November 22, 2013 at 18:04 PM EST
Nov 22 (Reuters) - U.S. Food and Drug Administration: * U.S. Food and Drug Administration says approved Olysio (simeprevir), a new
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.